Biosig Technologies (BSGM) Competitors $4.29 -0.33 (-7.14%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$4.32 +0.04 (+0.82%) As of 08/1/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BSGM vs. ZIMV, BFLY, DCTH, TMCI, OM, SNWV, RXST, CLPT, CATX, and NNOXShould you be buying Biosig Technologies stock or one of its competitors? The main competitors of Biosig Technologies include ZimVie (ZIMV), Butterfly Network (BFLY), Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Outset Medical (OM), Sanuwave Health (SNWV), RxSight (RXST), ClearPoint Neuro (CLPT), Perspective Therapeutics (CATX), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry. Biosig Technologies vs. Its Competitors ZimVie Butterfly Network Delcath Systems Treace Medical Concepts Outset Medical Sanuwave Health RxSight ClearPoint Neuro Perspective Therapeutics Nano-X Imaging Biosig Technologies (NASDAQ:BSGM) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment. Do analysts rate BSGM or ZIMV? Biosig Technologies currently has a consensus target price of $10.00, indicating a potential upside of 133.10%. ZimVie has a consensus target price of $17.75, indicating a potential downside of 5.38%. Given Biosig Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe Biosig Technologies is more favorable than ZimVie.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biosig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00ZimVie 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer BSGM or ZIMV? In the previous week, ZimVie had 8 more articles in the media than Biosig Technologies. MarketBeat recorded 9 mentions for ZimVie and 1 mentions for Biosig Technologies. ZimVie's average media sentiment score of 0.49 beat Biosig Technologies' score of 0.45 indicating that ZimVie is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biosig Technologies 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ZimVie 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is BSGM or ZIMV more profitable? Biosig Technologies has a net margin of 0.00% compared to ZimVie's net margin of -4.39%. ZimVie's return on equity of 6.37% beat Biosig Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Biosig TechnologiesN/A -5,336.99% -398.16% ZimVie -4.39%6.37%3.34% Which has preferable earnings & valuation, BSGM or ZIMV? Biosig Technologies has higher earnings, but lower revenue than ZimVie. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiosig Technologies$40K2,927.93-$10.33MN/AN/AZimVie$449.75M1.16-$25.83M-$0.70-26.80 Which has more volatility & risk, BSGM or ZIMV? Biosig Technologies has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.19, suggesting that its stock price is 119% more volatile than the S&P 500. Do institutionals and insiders have more ownership in BSGM or ZIMV? 7.2% of Biosig Technologies shares are owned by institutional investors. Comparatively, 95.6% of ZimVie shares are owned by institutional investors. 17.0% of Biosig Technologies shares are owned by company insiders. Comparatively, 3.0% of ZimVie shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryBiosig Technologies and ZimVie tied by winning 7 of the 14 factors compared between the two stocks. Get Biosig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BSGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBiosig TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$117.10M$6.80B$5.53B$9.37BDividend YieldN/A1.31%4.74%4.12%P/E RatioN/A20.9028.8823.79Price / Sales2,927.9359.12440.8796.30Price / CashN/A20.4535.0757.18Price / Book-47.674.468.255.54Net Income-$10.33M$176.39M$3.25B$259.88M7 Day Performance-10.44%-5.27%-3.75%-4.67%1 Month Performance-55.54%-3.94%4.26%4.40%1 Year Performance1,091.67%8.26%25.83%17.91% Biosig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBiosig Technologies2.069 of 5 stars$4.29-7.1%$10.00+133.1%+972.2%$117.10M$40K0.0050Gap DownZIMVZimVie0.9358 of 5 stars$18.82+0.5%$17.00-9.7%-8.0%$521.30M$449.75M-26.511,770News CoverageEarnings ReportUpcoming EarningsAnalyst DowngradeBFLYButterfly Network2.4237 of 5 stars$1.93-2.0%$3.50+81.3%+36.9%$487.16M$82.06M-6.66460Trending NewsAnalyst DowngradeGap UpDCTHDelcath Systems2.6943 of 5 stars$11.41flat$24.00+110.3%+29.3%$397.37M$37.21M-22.8260Upcoming EarningsAnalyst UpgradeTMCITreace Medical Concepts2.4045 of 5 stars$5.75+0.9%$10.52+82.9%-19.0%$358.47M$209.36M-6.76250News CoveragePositive NewsUpcoming EarningsOMOutset Medical1.6981 of 5 stars$18.04-2.6%$29.50+63.5%-71.4%$328.39M$115.27M-0.62520Upcoming EarningsSNWVSanuwave Health2.2711 of 5 stars$35.75-5.6%N/AN/A$324.43M$32.63M-7.8540News CoverageAnalyst ForecastAnalyst RevisionRXSTRxSight3.3645 of 5 stars$7.87-1.3%$17.50+122.4%-82.4%$323.88M$139.93M-11.75220Trending NewsUpcoming EarningsCLPTClearPoint Neuro2.8024 of 5 stars$10.97-2.3%$25.00+127.9%+47.1%$314.32M$31.39M-14.43110Analyst ForecastGap DownCATXPerspective Therapeutics2.3898 of 5 stars$4.12+1.5%$12.56+204.7%-72.5%$305.82MN/A0.0070News CoverageNNOXNano-X Imaging2.3603 of 5 stars$5.14-1.2%$9.50+84.8%-41.1%$300.45M$11.28M-5.71190News CoveragePositive News Related Companies and Tools Related Companies ZimVie Competitors Butterfly Network Competitors Delcath Systems Competitors Treace Medical Concepts Competitors Outset Medical Competitors Sanuwave Health Competitors RxSight Competitors ClearPoint Neuro Competitors Perspective Therapeutics Competitors Nano-X Imaging Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BSGM) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biosig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biosig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BSGM Stock Alerts